Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary intervention

BMC Medical Research Methodology

Volumn 9, Issue 1, 2009, Pages

  Ethgen, Morgane ^a,b,c   Boutron, Lsabelle ^a,b,c   Steg, Philippe Gabriel ^a,b,c   Roy, Carine ^a,b,c   Ravaud, Philippe ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY STENT; EXTERNAL VALIDITY; HEALTH CARE PERSONNEL; HUMAN; INTERNAL VALIDITY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME; META ANALYSIS; METHODOLOGY; OUTCOME ASSESSMENT; STANDARD; STATISTICS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS;

EID: 66349085614     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-9-24     Document Type: Article

References (33)

1. The state of the stent: current practices, controversies, and future trends. PW Serruys MJ Kutryk, The American journal of cardiology 1996 78 3A 4 7 10.1016/S0002-9149(96)00485-7 8751839 (Pubitemid 26277732)
2. Randomised trials, human nature, and reporting guidelines. KF Schulz, Lancet 1996 348 9027 596 598 10.1016/S0140-6736(96)01201-9 8774577
3. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. DG Altman KF Schulz D Moher M Egger F Davidoff D Elbourne PC Gotzsche T Lang, Ann Intern Med 2001 134 8 663 694 11304107 (Pubitemid 32322245)
4. Volume-outcome relationships for percutaneous coronary interventions in the stent era. EL Hannan C Wu G Walford SB King 3rd DR Holmes Jr JA Ambrose S Sharma S Katz LT Clark RH Jones, Circulation 2005 112 8 1171 1179 10.1161/CIRCULATIONAHA.104.528455 16103238
5. Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. I Boutron F Tubach B Giraudeau P Ravaud, Jama 2003 290 8 1062 1070 10.1001/jama.290.8.1062 12941679
6. Blinding was judged more difficult to achieve and maintain in non-pharmacological than pharmacological trials. I Boutron F Tubach B Giraudeau P Ravaud, J Clin Epidemiol 2004 57 6 543 550 10.1016/j.jclinepi.2003.12.010 15246122
7. Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry. C Spaulding MC Morice B Lancelin S El Haddad E Lepage S Bataille JP Tresca X Mouranche S Fosse M Monchi, Eur Heart J 2006 27 9 1054 1060 10.1093/eurheartj/ehi843 16569652
8. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). E Braunwald EM Antman JW Beasley RM Califf MD Cheitlin JS Hochman RH Jones D Kereiakes J Kupersmith TN Levin, J Am Coll Cardiol 2002 40 7 1366 1374 10.1016/S0735-1097(02)02336-7 12383588
9. Coronary artery stents: a rapid systematic review and economic evaluation. R Hill A Bagust A Bakhai R Dickson Y Dundar A Haycox R Mujica Mota A Reaney D Roberts P Williamson, Health Technol Assess 2004 8 35 iii-iv 1-242 15361315 (Pubitemid 39591602)
10. External validity of randomised controlled trials: "to whom do the results of this trial apply?". PM Rothwell, Lancet 2005 365 9453 82 93 10.1016/S0140-6736(04)17670-8 15639683
11. External validity of clinical trials in acute myocardial infarction. PG Steg J Lopez-Sendon E Lopez de Sa SG Goodman JM Gore FA Anderson Jr D Himbert J Allegrone F Van de Werf, Arch Intern Med 2007 167 1 68 73 10.1001/archinte.167. 1.68 17210880
12. A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. I Boutron D Moher P Tugwell B Giraudeau S Poiraudeau R Nizard P Ravaud, J Clin Epidemiol 2005 58 12 1233 1240 10.1016/j.jclinepi.2005.05.004 16291467
13. Clustering by health professional in individually randomised trials. KJ Lee SG Thompson, Bmj 2005 330 7483 142 144 15649931 10.1136/bmj.330.7483.142 (Pubitemid 40138505)
14. The use of random effects models to allow for clustering in individually randomized trials. KJ Lee SG Thompson, Clin Trials 2005 2 2 163 173 10.1191/1740774505cn082oa 16279138
15. Factors that limit the quality, number and progress of randomised controlled trials. RJ Prescott CE Counsell WJ Gillespie AM Grant IT Russell S Kiauka IR Colthart S Ross SM Shepherd D Russell, Health Technol Assess 1999 3 20 1 143 10683591 (Pubitemid 30014709)
16. Quality of reporting of randomized trials as a measure of methodologic quality. K Huwiler-Muntener P Juni C Junker M Egger, Jama 2002 287 21 2801 2804 10.1001/jama.287.21.2801 12038917 (Pubitemid 34591968)
17. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. EM Balk PA Bonis H Moskowitz CH Schmid JP Ioannidis C Wang J Lau, Jama 2002 287 22 2973 2982 10.1001/jama.287.22.2973 12052127 (Pubitemid 34620001)
18. Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence. R Tung S Kaul GA Diamond PK Shah, Ann Intern Med 2006 144 12 913 919 16785479 (Pubitemid 46768132)
19. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. KF Schulz I Chalmers RJ Hayes DG Altman, Jama 1995 273 5 408 412 10.1001/jama.273.5.408 7823387
20. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. EJ Topol SE Nissen, Circulation 1995 92 8 2333 2342 7554219
21. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. I Ferreira-Gonzalez JW Busse D Heels-Ansdell VM Montori EA Akl DM Bryant P Alonso-Coello J Alonso A Worster S Upadhye, Bmj 2007 334 7597 786 17403713 10.1136/bmj.39136.682083.AE
22. Key issues in end point selection for heart failure trials: composite end points. JD Neaton G Gray BD Zuckerman MA Konstam, J Card Fail 2005 11 8 567 575 10.1016/j.cardfail.2005.08.350 16230258
23. Composite outcomes in randomized trials: greater precision but with greater uncertainty? N Freemantle M Calvert J Wood J Eastaugh C Griffin, Jama 2003 289 19 2554 2559 10.1001/jama.289.19.2554 12759327
24. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. S Silber P Albertsson FF Aviles PG Camici A Colombo C Hamm E Jorgensen J Marco JE Nordrehaug W Ruzyllo, Eur Heart J 2005 26 8 804 847 10.1093/eurheartj/ehi138 15769784
25. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). SC Smith Jr TE Feldman JW Hirshfeld Jr AK Jacobs MJ Kern SB King 3rd DA Morrison WW O'Neil HV Schaff PL Whitlow, Circulation 2006 113 7 e166 286 10.1161/CIRCULATIONAHA.106. 173220 16490830
26. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. PD McGrath DE Wennberg JD Dickens Jr AE Siewers FL Lucas DJ Malenka MA Kellett Jr TJ Ryan Jr, Jama 2000 284 24 3139 3144 10.1001/jama.284.24.3139 11135777 (Pubitemid 32039076)
27. Operator volume and outcomes of primary angioplasty for acute myocardial infarction in a single high-volume centre. A Politi M Galli S Zerboni R Michi F De Marco M Llambro G Ferrari, J Cardiovasc Med (Hagerstown) 2006 7 10 761 767 17001238 (Pubitemid 44454832)
28. Volume-outcome relation for hospitals performing angioplasty for acute myocardial infarction: results from the Nationwide Japanese Registry. M Tsuchihashi H Tsutsui H Tada M Shihara A Takeshita S Kono, Circ J 2004 68 10 887 891 10.1253/circj.68.887 15459459
29. Operator volume and outcome of patients undergoing coronary stent placement. A Kastrati F-J Neumann A Schomig, 1998 32 970 976 9768719
30. Strategies for Reducing the Door-to-Balloon Time in Acute Myocardial Infarction. EH Bradley J Herrin Y Wang BA Barton TR Webster JA Mattera SA Roumanis JP Curtis BK Nallamothu DJ Magid, 2006 355 2308 2320 17101617
31. Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysis. BK Nallamothu Y Wang DJ Magid RL McNamara J Herrin EH Bradley ER Bates CV Pollack Jr HM Krumholz, Circulation 2006 113 2 222 229 10.1161/CIRCULATIONAHA.105.578195 16401769
32. Need for expertise based randomised controlled trials. PJ Devereaux M Bhandari M Clarke VM Montori DJ Cook S Yusuf DL Sackett CS Cina SD Walter B Haynes, Bmj 2005 330 7482 88 15637373 10.1136/bmj.330.7482.88 (Pubitemid 40093187)
33. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? D Moher B Pham A Jones DJ Cook AR Jadad M Moher P Tugwell TP Klassen, Lancet 1998 352 9128 609 613 10.1016/S0140-6736(98)01085-X 9746022